Literature DB >> 17660411

In vitro expression of the first capsule gene of Streptococcus pneumoniae, cpsA, is associated with serotype-specific colonization prevalence and invasiveness.

Lucy J Hathaway1, Patrick Bättig1, Kathrin Mühlemann2,1.   

Abstract

The polysaccharide capsule protects Streptococcus pneumoniae from phagocytosis during invasive infection, but inhibits adherence. Serotypes vary in their tendency to colonize the nasopharynx or cause invasive infection, and differences in capsule expression may play a role. Expression of the first gene of the capsule operon, cpsA, during in vitro growth of 43 clinical isolates representing 14 common pneumococcal serotypes was compared using quantitative RT-PCR. Serotypes associated with invasive infection (1, 4, 5, 7F, 8 and 14) expressed an average of twofold (P=0.0003) more cpsA than serotypes associated with nasopharyngeal colonization (6A, 6B, 9V, 15, 18C, 19F, 23F and 33). There was no difference in cpsA expression in response to growth under environmental oxygen or anaerobic conditions between the invasive and colonizing transparent strains tested: oxygen concentration did not affect cpsA expression in either the invasive or the colonizing transparent strains. Expression of cpsA at OD(600) 0.6 tended to be greater in strains with a longer lag phase during in vitro growth (P=0.07). Therefore, cpsA expression under ambient oxygen concentrations correlates with serotype-specific invasiveness and is inversely associated with the prevalence of serotype-specific carriage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17660411     DOI: 10.1099/mic.0.2006/005066-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  16 in total

1.  Interleukin-1β regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intercellular cooperation between pulmonary epithelial cells and macrophages.

Authors:  Helen M Marriott; Kate A Gascoyne; Ravi Gowda; Ian Geary; Martin J H Nicklin; Francesco Iannelli; Gianni Pozzi; Timothy J Mitchell; Moira K B Whyte; Ian Sabroe; David H Dockrell
Journal:  Infect Immun       Date:  2011-12-12       Impact factor: 3.441

2.  A low-affinity penicillin-binding protein 2x variant is required for heteroresistance in Streptococcus pneumoniae.

Authors:  Hansjürg Engel; Moana Mika; Dalia Denapaite; Regine Hakenbeck; Kathrin Mühlemann; Manfred Heller; Lucy J Hathaway; Markus Hilty
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

Review 3.  Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection.

Authors:  A P Hakansson; C J Orihuela; D Bogaert
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

4.  Heteroresistance to fosfomycin is predominant in Streptococcus pneumoniae and depends on the murA1 gene.

Authors:  Hansjürg Engel; Javier Gutiérrez-Fernández; Christine Flückiger; Martín Martínez-Ripoll; Kathrin Mühlemann; Juan A Hermoso; Markus Hilty; Lucy J Hathaway
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

5.  Capsule type of Streptococcus pneumoniae determines growth phenotype.

Authors:  Lucy J Hathaway; Silvio D Brugger; Brigitte Morand; Mathieu Bangert; Jeannine U Rotzetter; Christoph Hauser; Werner A Graber; Suzanna Gore; Aras Kadioglu; Kathrin Mühlemann
Journal:  PLoS Pathog       Date:  2012-03-08       Impact factor: 6.823

6.  Streptococcus pneumoniae detects and responds to foreign bacterial peptide fragments in its environment.

Authors:  Lucy J Hathaway; Patrick Bättig; Sandra Reber; Jeannine U Rotzetter; Suzanne Aebi; Christoph Hauser; Manfred Heller; Aras Kadioglu; Kathrin Mühlemann
Journal:  Open Biol       Date:  2014-04-09       Impact factor: 6.411

7.  Transcriptional regulation of the capsular polysaccharide biosynthesis locus of streptococcus pneumoniae: a bioinformatic analysis.

Authors:  Miriam Moscoso; Ernesto García
Journal:  DNA Res       Date:  2009-05-08       Impact factor: 4.458

8.  Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates.

Authors:  Luanne Hall-Stoodley; Laura Nistico; Karthik Sambanthamoorthy; Bethany Dice; Duc Nguyen; William J Mershon; Candice Johnson; Fen Ze Hu; Paul Stoodley; Garth D Ehrlich; J Christopher Post
Journal:  BMC Microbiol       Date:  2008-10-08       Impact factor: 3.605

9.  The pneumococcal polysaccharide capsule and pneumolysin differentially affect CXCL8 and IL-6 release from cells of the upper and lower respiratory tract.

Authors:  Eliane Küng; William R Coward; Daniel R Neill; Hesham A Malak; Kathrin Mühlemann; Aras Kadioglu; Markus Hilty; Lucy J Hathaway
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

10.  A point mutation in cpsE renders Streptococcus pneumoniae nonencapsulated and enhances its growth, adherence and competence.

Authors:  Thierry O Schaffner; Jason Hinds; Katherine A Gould; Daniel Wüthrich; Rémy Bruggmann; Marianne Küffer; Kathrin Mühlemann; Markus Hilty; Lucy J Hathaway
Journal:  BMC Microbiol       Date:  2014-08-28       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.